FierceBiotech ٢٣ أبريل ٢٠٢٦ Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
BioPharma Dive ٢٣ أبريل ٢٠٢٦ Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs
Roche Media ٢٣ أبريل ٢٠٢٦ Roche Q1 earnings suffer blood bath, but currency headwinds aren’t the only culprit - Fierce Pharma
FierceBiotech ٢٣ أبريل ٢٠٢٦ From debt to ‘acceptable’ prices: Roche CEO lists 3 reasons for sitting out Big Pharma M&A spree
Roche Media ٢٣ أبريل ٢٠٢٦ From debt to ‘acceptable’ prices: Roche CEO lists 3 reasons for sitting out Big Pharma M&A spree - Fierce Biotech
Roche Media ٢٢ أبريل ٢٠٢٦ The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy - statnews.com
FierceBiotech ٢٢ أبريل ٢٠٢٦ Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials
Roche Media ٢١ أبريل ٢٠٢٦ With successful trials, Roche takes its MS drug to regulators, but safety questions loom - statnews.com
Roche Media ٢١ أبريل ٢٠٢٦ Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials - Fierce Biotech
FierceBiotech ٢٠ أبريل ٢٠٢٦ AACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugs
Roche Media ١٧ أبريل ٢٠٢٦ Roche builds MRD testing arsenal in $595m Saga Diagnostics buyout - Medical Device Network
Roche Media ١٧ أبريل ٢٠٢٦ Roche affiliate to acquire Triangle diagnostics firm for up to $595M - The Business Journals
Roche Media ١٦ أبريل ٢٠٢٦ Roche to launch another Elevidys trial, with eyes on European approval - statnews.com
Roche Media ١٥ أبريل ٢٠٢٦ Could Roche’s Top-Selling Drug Be Harming Women with Primary Progressive Multiple Sclerosis? - Bioengineer.org
Endpoints News ٩ أبريل ٢٠٢٦ Roche dips into DACs with existing partner C4 Therapeutics for $20M upfront
FierceBiotech ٩ أبريل ٢٠٢٦ Roche takes 'leap of faith' with $20M bet on C4T’s antibody-targeted protein degraders